查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1714251

大分子生物分析技术市场－全球产业规模、份额、趋势、机会和预测，按产品和服务（产品、服务）、应用、地区和竞争细分，2020-2030 年

Large Molecule Bioanalytical Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Products & Services (Product, Service), By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球大分子生物分析技术市场价值为 95.4 亿美元，预计到 2030 年将达到 172.1 亿美元，预测期内复合年增长率将达到 10.31%。生物製剂和生物相似药管道的不断扩大，以及在治疗慢性和危及生命的疾病方面对生物疗法而非小分子疗法的日益青睐，推动了市场的成长。这些先进的治疗方法需要精确的分析工具，以便在药物开发的所有阶段进行准确的表征、量化和验证。单株抗体、重组蛋白和基因疗法的使用增加促使製药公司和研究机构投资高通量、敏感技术。混合分析平台、数位自动化和人工智慧整合等新兴趋势正在进一步改变生物分析工作流程。儘管该行业受益于技术进步，但它仍然面临着高资本投入和严格监管标准相关的挑战。生物製剂的复杂性也要求分析方法不断创新和标准化，从而强化先进生物分析技术在生物製药产业的关键角色。

市场概览
预测期 2026-2030
2024年市场规模 95.4亿美元
2030年市场规模 172.1亿美元
2025-2030 年复合年增长率 10.31%
成长最快的领域 细胞与基因治疗
最大的市场 北美洲

关键市场驱动因素

对生物製剂和生物相似药的需求不断增长

主要市场挑战

先进分析仪器成本高昂

主要市场趋势

采用混合分析技术

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球大分子生物分析技术市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依产品及服务（产品（耗材及配件、仪器、试剂及试剂盒）、服务）
    • 依应用（生物製剂、寡核苷酸衍生药物和分子、病毒载体、细胞和基因治疗、奈米颗粒和聚合物、其他）
    • 按公司分类（2024）
    • 按地区
  • 市场地图

第六章：北美大分子生物分析技术市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章：欧洲大分子生物分析技术市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太大分子生物分析技术市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章：南美大分子生物分析技术市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东与非洲大分子生物分析技术市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如有）
  • 最新动态

第 13 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章：竞争格局

  • Intertek Group plc
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Solvias
  • Bio-Techne
  • Waters Corporation
  • Verder Scientific GmbH & Co. KG
  • Charles River Laboratories
  • Merck KGaA
  • Cergentis BV

第 15 章：策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 28302

The global market for large molecule bioanalytical technologies was valued at USD 9.54 billion in 2024 and is projected to reach USD 17.21 billion by 2030, registering a robust CAGR of 10.31% during the forecast period. Market growth is being fueled by the expanding pipeline of biologics and biosimilars, along with the increasing preference for biologic therapies over small molecules in treating chronic and life-threatening conditions. These advanced therapeutics require precise analytical tools for accurate characterization, quantification, and validation across all phases of drug development. The rise in the use of monoclonal antibodies, recombinant proteins, and gene therapies is prompting pharmaceutical companies and research organizations to invest in high-throughput, sensitive technologies. Emerging trends such as hybrid analytical platforms, digital automation, and AI integration are further transforming bioanalytical workflows. While the sector benefits from technological progress, it continues to face challenges related to high capital investment and stringent regulatory standards. The complexity of biologics also necessitates ongoing innovation and standardization in analytical methodologies, reinforcing the critical role of advanced bioanalytical technologies in the biopharmaceutical industry.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 9.54 Billion
Market Size 2030USD 17.21 Billion
CAGR 2025-203010.31%
Fastest Growing SegmentCell & Gene Therapy
Largest MarketNorth America

Key Market Drivers

Growing Demand for Biologics and Biosimilars

The global shift toward biologics and biosimilars as preferred therapeutic modalities is a key driver of demand for large molecule bioanalytical technologies. Biologics, including monoclonal antibodies and therapeutic proteins, offer high specificity and efficacy in treating complex conditions such as cancer and autoimmune diseases. As these therapies require extensive analytical testing throughout their development and regulatory lifecycle, the need for reliable, high-precision bioanalytical platforms has grown significantly. Additionally, regulatory mandates for biosimilar comparability studies further intensify the demand for advanced analytical solutions to evaluate safety, efficacy, and quality. The increasing adoption of biologics across diverse therapeutic areas ensures a sustained need for robust, sensitive, and scalable bioanalytical technologies.

Key Market Challenges

High Costs of Advanced Analytical Instruments

The adoption of large molecule bioanalytical technologies is often hindered by the high costs associated with procuring and operating advanced instruments. Technologies such as LC-MS/MS and surface plasmon resonance systems require substantial capital investment and ongoing operational expenses. These costs include maintenance, calibration, consumables, and software licensing. For small and mid-sized laboratories or emerging biotech firms, such financial demands can be a major constraint. This challenge is compounded by the need for highly skilled personnel to operate and maintain these systems, limiting market penetration in resource-constrained settings.

Key Market Trends

Adoption of Hybrid Analytical Techniques

An emerging trend in the market is the increased use of hybrid analytical methods, particularly those that integrate ligand-binding assays with LC-MS/MS. This combination enhances both sensitivity and specificity, making it ideal for analyzing complex biologics such as monoclonal antibodies and fusion proteins. These techniques are especially useful in pharmacokinetics, pharmacodynamics, and immunogenicity studies, where the detection of trace levels of analytes in complex biological samples is critical. Regulatory bodies are acknowledging the value of these integrated approaches, further promoting their adoption in both early-stage research and clinical development.

Key Market Players

  • Intertek Group plc
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Solvias
  • Bio-Techne
  • Waters Corporation
  • Verder Scientific GmbH & Co. KG
  • Charles River Laboratories
  • Merck KGaA
  • Cergentis B.V.

Report Scope:

In this report, the Global Large Molecule Bioanalytical Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Large Molecule Bioanalytical Technologies Market, By Products & Services:

  • Product

Consumables & Accessories

Instruments

Reagents & Kits

  • Service

Large Molecule Bioanalytical Technologies Market, By Application:

  • Biologics
  • Oligonucleotide Derived Drugs & Molecules
  • Viral Vector
  • Cell & Gene Therapy
  • Nanoparticles & Polymers
  • Others

Large Molecule Bioanalytical Technologies Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Large Molecule Bioanalytical Technologies Market.

Available Customizations:

Global Large Molecule Bioanalytical Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Large Molecule Bioanalytical Technologies Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Products & Services (Product (Consumables & Accessories, Instruments, Reagents & Kits), Service)
    • 5.2.2. By Application (Biologics, Oligonucleotide Derived Drugs & Molecules, Viral Vector, Cell & Gene Therapy, Nanoparticles & Polymers, Others)
    • 5.2.3. By Company (2024)
    • 5.2.4. By Region
  • 5.3. Market Map

6. North America Large Molecule Bioanalytical Technologies Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Large Molecule Bioanalytical Technologies Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Products & Services
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Large Molecule Bioanalytical Technologies Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Products & Services
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Large Molecule Bioanalytical Technologies Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Products & Services
        • 6.3.3.2.2. By Application

7. Europe Large Molecule Bioanalytical Technologies Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products & Services
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products & Services
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products & Services
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Products & Services
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Products & Services
        • 7.3.5.2.2. By Application

8. Asia-Pacific Large Molecule Bioanalytical Technologies Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products & Services
        • 8.3.1.2.2. By Application
    • 8.3.2. India Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products & Services
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products & Services
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products & Services
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products & Services
        • 8.3.5.2.2. By Application

9. South America Large Molecule Bioanalytical Technologies Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Large Molecule Bioanalytical Technologies Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products & Services
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Large Molecule Bioanalytical Technologies Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products & Services
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Large Molecule Bioanalytical Technologies Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products & Services
        • 9.3.3.2.2. By Application

10. Middle East and Africa Large Molecule Bioanalytical Technologies Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Large Molecule Bioanalytical Technologies Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products & Services
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Large Molecule Bioanalytical Technologies Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products & Services
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Large Molecule Bioanalytical Technologies Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products & Services
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Intertek Group plc
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. F. Hoffmann-La Roche Ltd
  • 14.3. Bio-Rad Laboratories, Inc.
  • 14.4. Solvias
  • 14.5. Bio-Techne
  • 14.6. Waters Corporation
  • 14.7. Verder Scientific GmbH & Co. KG
  • 14.8. Charles River Laboratories
  • 14.9. Merck KGaA
  • 14.10. Cergentis B.V.

15. Strategic Recommendations

16. About Us & Disclaimer